Blood pressure changes during treatment with recombinant human erythropoietin.
Samtleben
W
W
Nephrology Division, Klinikum München-Grosshadern, Ludwigs-Maximilians University, München, FRG.
Baldamus
C A
CA
Bommer
J
J
Fassbinder
W
W
Nonnast-Daniel
B
B
Gurland
H J
HJ
D000328:Adult; D000740:Anemia / Q000209:etiology / Q000628:therapy*; D001794:Blood Pressure; D002986:Clinical Trials as Topic; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000209:etiology*; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D011994:Recombinant Proteins / Q000627:therapeutic use*
D011994:Recombinant Proteins; D004921:Erythropoietin